Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Olin (OLN) Shares Up 21% in 6 months: What's Driving the Stock?

Published 12/23/2021, 08:26 PM
Updated 07/09/2023, 06:31 AM

Olin (NYSE:OLN) Corporation’s OLN shares have jumped 21.5% in the past six months outperforming the industry’s rise of 0.2%. The company has also topped the S&P 500’s 11.4% rise over the same period.

Image Source: Zacks Investment Research

Let’s dive into the factors behind this Zacks Rank #1 (Strong Buy) stock’s price appreciation.

What’s Driving the Stock?

Olin is reaping the benefits from the Lake City U.S. Army contract, productivity actions and investment in the Information Technology (IT) project. Better-than-expected earnings performance and upbeat prospects have also contributed to the rally in the company’s shares.

The company’s Chlor Alkali Products & Vinyls and Epoxy business units are benefiting from higher prices, and its Winchester segment stands to gain from the Lake City U.S. Army ammunition contract. OLN looks to pump up the annual profitability of the unit through the multi-year contract. Sales from the Winchester segment surged 94% year over year in the third quarter of 2021, on the back of higher commercial and military sales, including ammunition produced at Lake City and higher commercial ammunition pricing.

Olin looks to drive improvement in its cost structure and enhance productivity through a number of projects. It currently has more than 1,200 active productivity projects that are expected to contribute to savings in 2021. It expects productivity measures to deliver $100 million of net savings in 2021.

The company is also aiming to improve its net debt to adjusted EBITDA ratio through a combination of improved adjusted EBITDA, disciplined capital spending and debt reduction by the end of 2021. For full-year 2021, it targets debt reduction of roughly $1.1 billion by using the cash generated from operations.

Olin is also focused on boosting shareholders' returns. Last month, it announced that its board approved a new $1 billion share repurchase program. It repurchased around 1.5 million shares of common stock for $68.3 million in the third quarter.

Its investment in the IT project promises cost and other benefits to the company. The project involves the implementation of necessary IT infrastructure and is expected to maximize cost-effectiveness, efficiency and control over its global chemical operations by standardizing business processes.

Olin's earnings estimates have also been going up over the past two months. The Zacks Consensus Estimate for 2021 has increased around 19% and the same for fourth-quarter 2021 has gone up 54%. The favorable estimate revisions instill investor confidence in the stock.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Key Picks

Some other top-ranked stocks from the basic materials space are AdvanSix (NYSE:ASIX) Inc. ASIX, sporting a Zacks Rank #1 and Univar (NYSE:UNVR) Solutions Inc. UNVR and The Chemours Company (NYSE:CC) CC, both carrying a Zacks Rank #2 (Buy), and You can see the complete list of today’s Zacks #1 Rank stocks here.

AdvanSix has an expected earnings growth rate of 197% for the current year. The Zacks Consensus Estimate for its current-year earnings has been revised 14.1% upward over the past 60 days.

AdvanSix beat the Zacks Consensus Estimate for earnings in the four trailing quarters, with the earnings surprise being 47%, on average. ASIX’s shares have also surged 118.4% over a year.

Univar has an expected earnings growth rate of 55.2% for the current year. The Zacks Consensus Estimate for its current-year earnings has been revised 9% upward over the past 60 days.

Univar beat the Zacks Consensus Estimate for earnings in the four trailing quarters, with the earnings surprise being 24.1%, on average. UNVR’s shares have rallied 46.9% over a year.

Chemours has an expected earnings growth rate of 105.1% for the current year. The Zacks Consensus Estimate for CC’s earnings for the current year has been revised 10% upward in the past 60 days.

Chemours beat the Zacks Consensus Estimate for earnings in each of the last four quarters. The company delivered a trailing four-quarter earnings surprise of roughly 34.2%, on average. CC has gained 17.8% over a year.


More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.

Click here for the 4 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Olin Corporation (OLN): Free Stock Analysis Report

The Chemours Company (CC): Free Stock Analysis Report

Univar Solutions Inc. (UNVR): Free Stock Analysis Report

AdvanSix (ASIX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.